Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-11-05

FDA Approved: IOPIDINE 1% — Supplemental Application (Harrow Eye, LLC)

View source ↗

Summary

The FDA approved a supplemental application to market IOPIDINE 1% (apraclonidine hydrochloride ophthalmic solution) under Harrow Eye, LLC. This introduces a new…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IOPIDINE 1% (APRACLONIDINE HYDROCHLORIDE OPHTHALMIC SOLUTION)

Snippet

SUPPL AP for IOPIDINE 1% (APRACLONIDINE HYDROCHLORIDE OPHTHALMIC SOLUTION)